Enhancement of MDM2 inhibitory effects through blocking nuclear export mechanisms in ovarian cancer cells

被引:7
作者
Alzahrani, Amal [1 ,2 ,3 ]
Natarajan, Umamaheswari [1 ]
Rathinavelu, Appu [1 ,3 ]
机构
[1] Nova Southeastern Univ, Rumbaugh Goodwin Inst Canc Res, 3321 Coll Ave, Ft Lauderdale, FL 33314 USA
[2] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia
[3] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL USA
关键词
RG-7388; Selinexor; p53; p21; Apoptosis; SELECTIVE INHIBITOR; PROGNOSTIC-FACTOR; PHASE-I; CRM1; SELINEXOR; EXPRESSION; PROTEIN; KPT-330; 1ST-IN-CLASS; COMBINATION;
D O I
10.1016/j.cancergen.2022.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over 90% of ovarian cancer cells exhibit p53 mutations or inactivation. In addition, p53 is exported outside of the nucleus by exportin-1 (XPO1), a protein that mediates the nuclear export of several cancer suppressor proteins. Overexpression of XPO1 is associated with resistance to chemotherapy, leading to poor prognosis in various cancers. The MDM2 inhibitor, RG-7388, is a known reactivator of p53 and has been tested with high interest as a therapeutic agent for cancer treatment. In addition, Selinexor, which is a second-generation selective inhibitor of nuclear export (SINE), is known to cause an accumulation of p53 in the nucleus and is also being explored as a therapy potentiating agent in combination treatments. This study was conducted to assess the efficacy of RG-7388 in combination with Selinexor for treating ovarian cancer. A combination of Selinexor and RG-7388 treatments was able to reduce the cell viability compared to individual treatments. In addition, the combination treatment revealed significant up-regulation of several cancer suppressor proteins in the whole lysate, cytoplasm, and nucleus. Finally, our results confirm that the combination of Selinexor with RG-7388 can induce a caspase-mediated apoptotic mechanism via up-regulation of p53 and p21.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 45 条
[1]   Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia [J].
Alexander, Thomas B. ;
Lacayo, Norman J. ;
Choi, John K. ;
Ribeiro, Raul C. ;
Pui, Ching-Hon ;
Rubnitz, Jeffrey E. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) :4094-+
[2]   Pharmacodynamic and Genomic Markers Associated With Response to the XPO1/CRM1 Inhibitor Selinexor (KPT-330): A Report From the Pediatric Preclinical Testing Program [J].
Attiyeh, Edward F. ;
Maris, John M. ;
Lock, Richard ;
Reynolds, C. Patrick ;
Kang, Min H. ;
Carol, Hernan ;
Gorlick, Richard ;
Kolb, E. Anders ;
Keir, Stephen T. ;
Wu, Jianrong ;
Landesman, Yosef ;
Shacham, Sharon ;
Lyalin, Dmitry ;
Kurmasheva, Raushan T. ;
Houghton, Peter J. ;
Smith, Malcolm A. .
PEDIATRIC BLOOD & CANCER, 2016, 63 (02) :276-286
[3]   Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome A ROLE FOR THE NUCLEAR EXPORT SIGNAL, CRM1, AND AURORA A KINASE [J].
Brodie, Kirsty M. ;
Henderson, Beric R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (10) :7701-7716
[4]  
CDC, 2021, DIV CANC PREV CONTR
[5]   Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells [J].
Chiorazzi, Nicholas .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (03) :399-413
[6]   Protein and its Function Based on a Subcellular Localization [J].
Cmielova, Jana ;
Rezacova, M. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (12) :3502-3506
[7]   Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/ AKT/mTOR pathway [J].
Cui, Yingying ;
Zhou, Jing ;
Rong, Fengnian .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) :665-671
[8]   KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia [J].
Etchin, Julia ;
Sanda, Takaomi ;
Mansour, Marc R. ;
Kentsis, Alex ;
Montero, Joan ;
Le, Bonnie T. ;
Christie, Amanda L. ;
McCauley, Dilara ;
Rodig, Scott J. ;
Kauffman, Michael ;
Shacham, Sharon ;
Stone, Richard ;
Letai, Anthony ;
Kung, Andrew L. ;
Look, A. Thomas .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (01) :117-127
[9]   Dysregulation of apoptosis in hepatocellular carcinoma cells [J].
Fabregat, Isabel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (05) :513-520
[10]   CRM1 is an export receptor for leucine-rich nuclear export signals [J].
Fornerod, M ;
Ohno, M ;
Yoshida, M ;
Mattaj, IW .
CELL, 1997, 90 (06) :1051-1060